{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 28, "transaction_limit": 160, "filters": {"q": "", "ticker": "AVIR", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 28, "acquisition_count": 22, "disposal_count": 6, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 0.0, "disposal_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "flow_tone": "neutral", "largest_value_label": "$0", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 28, "value": "0.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$0"}], "days": [{"transaction_date": "2026-06-18", "acquisitions": 22, "disposals": 6, "total": 28, "bar_width": 100.0}], "side_mix": {"acquisitions": 22, "disposals": 6, "acquisition_share": 78.6, "disposal_share": 21.4}}, "company_flows": [{"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-06-18", "acquisitions": 22, "disposals": 6, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 78.6, "disposal_share": 21.4, "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}], "company_overview": [{"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-06-18", "filings": 28, "acquisitions": 22, "disposals": 6, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 78.6, "disposal_share": 21.4, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}], "transactions": [{"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "ADAMS, JEROME M.", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 26700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.856202+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "ADAMS, JEROME M.", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.857581+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "ADAMS, JEROME M.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.859096+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "ADAMS, JEROME M.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 37700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.854766+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BERGER, FRANKLIN M", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 26700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.877278+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BERGER, FRANKLIN M", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.890855+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BERGER, FRANKLIN M", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.889361+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BERGER, FRANKLIN M", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 37700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.881611+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BERMAN, HOWARD", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 26700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.880223+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "BERMAN, HOWARD", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 37700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.878772+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "DUNCAN, BARBARA GAYLE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.848537+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "DUNCAN, BARBARA GAYLE", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 37700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.872385+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "DUNCAN, BARBARA GAYLE", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 26700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.873841+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "DUNCAN, BARBARA GAYLE", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.875497+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "KIRSCH, ARTHUR S", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 26700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.853084+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "KIRSCH, ARTHUR S", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 37700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.851359+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "LUCIDI, BRUNO", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 26700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.886395+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "LUCIDI, BRUNO", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 37700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.887908+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "LUCIDI, BRUNO", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.883368+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "LUCIDI, BRUNO", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.884923+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "MURPHY, POLLY A.", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 26700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.862017+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "MURPHY, POLLY A.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 37700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.860534+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "MURPHY, POLLY A.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.864952+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "MURPHY, POLLY A.", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.863530+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "POLSKY, BRUCE", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.869338+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "POLSKY, BRUCE", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 37700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.866363+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "POLSKY, BRUCE", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 26700.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.867921+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}, {"symbol": "AVIR", "name": "Atea Pharmaceuticals\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "POLSKY, BRUCE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 29600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T22:07:51.870960+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/avir/", "research_links": {"chart": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/", "report": "/terminal/92837224-3fae-463b-a680-d1df1341d8c8/report/", "factor": "/factors/ticker/92837224-3fae-463b-a680-d1df1341d8c8/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}